Dr. Go began his academic career at the Mayo Clinic over four decades ago, investigating the regulation of human exocrine and endocrine pancreas in healthy and diseased states; subsequently, expanded towards nutrition, altered metabolism, and cancer prevention. His current research focuses on phytonutrient mechanism of action; utilizing molecular biology and metabolomic technologies. He is currently the Co-Director of the UCLA Agi Hirshberg Center for Pancreatic Diseases and the Editor-in-Chief of Pancreas.
Dr. Go joined the UCLA Department of Medicine in 1988 as the Executive Chair of the Department of Medicine after serving as the Director of the Division of Digestive Diseases and Nutrition at the NIH-National Institute of Diabetes, Digestive and Kidney Diseases (1985-1988). In 1996, he co-founded the UCLA Center for Human Nutrition with Dr. David Heber. Dr. Go was appointed jointly by the Secretaries of Department of Health and Human Services and Department of Agriculture to the US 2005 Dietary Guidelines Advisory Committee. He has authored and co-authored over 500 peer-review articles, book chapters, and editorials. He co-founded the American Pancreatic Association in 1969 and the societys Lifetime Achievement Award is named after him. In 2007, he was the American Gastroenterological Association Foundations Mentor Research Scholar Award Program honoree for having trained over 70 fellows and junior faculty, some of whom have now provided national and international leadership in gastroenterology, pancreatology, and nutrition. He was elected to the Board of Directors of the North American Neuroendocrine Tumor Society and served from 2006-2009 and currently is a member of their Executive Committee. Over the course of his career he has received numerous honors and recognition awards including the 2013 University of Santo Tomas Medical Alumni Association Most Outstanding Academic Achievement Award and the Mayo Foundation Distinguished Alumni Award in 2002.
B. Vaitheesvaran , J. Xu , J. Yee , Q.-Y. Lu , V. L. Go , G. G. Xiao , W.-N. Lee The Warburg effect: a balance of flux analysis Metabolomics, 2015; 11(4): 787-796.
Li, Yiwei MD; Go, Vay Liang W. MD; Sarkar, Fazlul H. PhD The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome Pancreas, 2015; 44(1): 1-10.
Lu Qing-Yi, Zhang Lifeng, Moro Aune, Chen Monica C, Harris Diane M, Eibl Guido, Go Vay-Liang W Detection of baicalin metabolites baicalein and oroxylin-a in mouse pancreas and pancreatic xenografts Pancreas, 2012; 41(4): 571-6.
Harris Diane M, Li Luyi, Chen Monica, Lagunero F Tracy, Go Vay Liang W, Boros Laszlo G Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75 Metabolomics : Official journal of the Metabolomic Society, 2012; 8(2): 201-210.
Does this profile need updating? Contact Us